• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    More On GENE

    Genetic Technologies Limited (GENE)

    -NasdaqCM
    0.38 Up 0.02(5.87%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:0.36
    Open:0.35
    Bid:0.24 x 200
    Ask:N/A
    1y Target Est:2.50
    Beta:-1.58
    Next Earnings Date:N/A
    Day's Range:0.34 - 0.38
    52wk Range:0.31 - 2.41
    Volume:166,362
    Avg Vol (3m):382,714
    Market Cap:8.44M
    P/E (ttm):N/A
    EPS (ttm):-0.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GENE

    Comparison

    Symbol% ChgMkt Cap
    GENEUp 5.87%8.44M
    ABTUp 0.33%69.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.36
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of genetic tests for breast and ovarian cancer, bowel and uterine cancer, and prostate cancer; neurogenetic diagnostic a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback